bioAffinity
  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
  • Careers
Select Page

Clinical Study for Non-Invasive Lung Cancer Test Reports Promising Results

by Maria Zannes | Sep 23, 2015 | Press Releases

SEPTEMBER 23, 2015 (SAN ANTONIO, TX ) bioAffinity Technologies, a privately held cancer diagnostics company, today announced that results from a 128-patient proof-of-concept clinical study for its non-invasive and quantitative assay for early-stage lung cancer were...
Next Entries »

Categories

  • Articles (27)
  • Events (38)
  • News (52)
  • Press Releases (127)
  • Publications (17)

Recent Posts

  • Case Study: CyPath® Lung Detects Stage 1A Lung Cancer in High-Risk Patient with Inconclusive Imaging July 9, 2025
  • bioAffinity Technologies Scientists Present Breakthrough Cancer Research at RNA Therapeutics Conference June 26, 2025
  • bioAffinity Technologies Expands Patent Portfolio with China Grant for siRNA-Based Cancer Therapy June 24, 2025
  • bioAffinity Technologies President and CEO Maria Zannes Appointed to American Lung Association in Texas’ Leadership Board June 11, 2025
  • bioAffinity Technologies Works With Cardinal Health™ OptiFreight® Logistics to Help Meet Demand for CyPath® Lung June 3, 2025

Learn About CyPath Lung

CyPath Lung Test

Main Menu

  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
  • Careers
Copyright © 2023 bioAffinity Technologies, Inc.